Biopol Chemicals Fund Raise of ₹31.25 Cr

Biopol Chemicals Board Meeting Date

Biopol Chemicals Limited scheduled a board meeting for November 5, 2026, to consider and approve its unaudited standalone financial results for the half-year ending September 2026.

Biopol Chemicals Other Announcement

Biopol Chemicals Limited has intimated the exchange regarding the non-applicability of the Corporate Governance Report for the quarter ended September 30, 2026.

Biopol Chemicals Management Change

Biopol Chemicals Limited regularised the appointment of Mr. Sukhomoy Das as an Independent Director for a five-year term, effective June 11, 2026, following shareholder approval.

Biopol Chemicals Annual General Meeting

Biopol Chemicals Limited held its 3rd Annual General Meeting on September 22, 2026, via video conferencing. The meeting transacted ordinary and special business items.

Biopol Chemicals Business Update

Biopol Chemicals Limited participated in the 53rd Dye+Chem Bangladesh 2026 International Expo held in Dhaka from September 2 to September 5, 2026.

Biopol Chemicals Price Movement Clarification

Biopol Chemicals Limited clarified that recent share price movements are entirely market-driven. The company confirmed it has no undisclosed material information affecting trading volume or price.

Pajson Agro India Fund Raise of ₹354.5 Cr

Pajson Agro's board approved a Rs.354.52 Crore preferential issue of 1,20,58,397 equity shares at Rs.294 each. Shareholder approval is sought at a meeting on 04-12-2026.

Value

₹354.5 Cr

Evonile Pharma Fund Raise of ₹900 Cr

Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.

Value

₹900.0 Cr

Lloyds Metals & Energy Fund Raise

Lloyds Metals and Energy's board approved a fund raise, with the mode of financing yet to be decided. Investors should watch for the eventual issuance structure and size.

Shlokka Dyes Fund Raise of ₹24.5 Cr

Shlokka Dyes board approved a ₹24.50 Crore preferential issue of equity shares and warrants. Shareholder approval is pending at a November 28, 2026 meeting.

Value

₹24.50 Cr

Crescentis Capital Fund Raise of ₹79.62 Cr

Crescentis Capital's board approved the Letter of Offer for a rights issue of 1,02,08,129 shares at Rs.78 each. The issue aggregates to Rs.7,962.34 lakhs, or about Rs.79.62 Crore, assuming full subscription.

Value

₹79.62 Cr

Execution

Issue opening November 16, 2026; closing November 27, 2026; listing on or about December 3, 2026

Acetech E-Commerce Fund Raise of ₹40 Cr

Acetech E-Commerce approved a ₹40 Crore Rights Issue and 70% acquisition of Unique Cookware (₹10.41 Crore). Both decisions will fund expansion into cookware and allied products.

Value

₹40.00 Cr